Skip to main content
. Author manuscript; available in PMC: 2007 Oct 1.
Published in final edited form as: Vaccine. 2006 Nov 7;25(8):1409–1415. doi: 10.1016/j.vaccine.2006.10.043

Table 1.

Peptides used in mini-gene vaccines.

Peptide Name Sequence Included in vaccine
Flk54 RGQRDLDWL pDd; pDd+Kd1
Flk210 TYQSIMYIV pKd; pKd+Dd2
Flk221 VGYRIYDVI pDd; pKd+Dd2
Flk366 WYRNGRPIE pKd; pDd+Kd1
Flk438 QYGTMQTLT pKd: pKd+Dd2
Flk741 LGCARAETL pDd; pDd+Kd1
Flk792 EGELKTGYL pDd; pKd+Dd2
Flk993 LYKDFLYTE pKd; pDd+Kd1
Flk1147* QRPSFSELV pDd; pDd+Kd1
Flk1153 ELVEHLGNL pKd; pKd+Dd2
*

The underlined Serines (S) residues indicate potential glycosylation sites, with the one in bold print being the most likely to be glycosylated.